Acta Neuropathologica

, Volume 125, Issue 3, pp 463–465

Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid

  • Eileen H. Bigio
  • Jane Y. Wu
  • Han-Xiang Deng
  • Esther N. Bit-Ivan
  • Qinwen Mao
  • Rakhee Ganti
  • Melanie Peterson
  • Nailah Siddique
  • Changiz Geula
  • Teepu Siddique
  • Marsel Mesulam
Correspondence

References

  1. 1.
    Cohen TJ, Lee VMY, Trojanowski JQ (2011) TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17:659–667PubMedCrossRefGoogle Scholar
  2. 2.
    Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, Langstom B, Kilander L (2008) In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging 35:100–106PubMedCrossRefGoogle Scholar
  3. 3.
    Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X, Rao EJ, Yang M, Ye H, Zhu L, Liu J, Zhang D, Buratti E, Baralle FE, Bigio EH, Mesulam M, Xu Q, Shen Y, Fushimi K, Wu JY (2011) An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxocity. Nat Struct Mol Biol 18:822–830PubMedCrossRefGoogle Scholar
  4. 4.
    Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang G, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol 55:306–319PubMedCrossRefGoogle Scholar
  5. 5.
    Lee EB, Lee VM-Y, Trojanowski JQ (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nature 13:38–50Google Scholar
  6. 6.
    Robinson JL, Geser F, Stieber A, Umoh M, Kwong LK, Van Deerlin VM, Lee VM-Y, Trojanowski JQ (2013) TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol 125:121–131. doi:10.1007/s00401-012-1055-8 PubMedCrossRefGoogle Scholar
  7. 7.
    Westermark GT, Johnson KH, Westermark P (1999) Staining methods for identification of amyloid in tissue. Methods Enzymol 309:3–25PubMedCrossRefGoogle Scholar
  8. 8.
    Wolozin B (2012) Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener 7:56. doi:10.1186/1750-1326-7-56 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Eileen H. Bigio
    • 1
    • 2
  • Jane Y. Wu
    • 3
    • 4
  • Han-Xiang Deng
    • 3
    • 5
  • Esther N. Bit-Ivan
    • 2
  • Qinwen Mao
    • 2
  • Rakhee Ganti
    • 1
  • Melanie Peterson
    • 1
  • Nailah Siddique
    • 3
    • 5
  • Changiz Geula
    • 1
  • Teepu Siddique
    • 3
    • 5
  • Marsel Mesulam
    • 1
    • 3
  1. 1.Cognitive Neurology and Alzheimer Disease CenterNorthwestern University Feinberg School of MedicineChicagoUSA
  2. 2.Department of PathologyNorthwestern University Feinberg School of MedicineChicagoUSA
  3. 3.Department of NeurologyNorthwestern University Feinberg School of MedicineChicagoUSA
  4. 4.Center for Genetic MedicineNorthwestern University Feinberg School of MedicineChicagoUSA
  5. 5.Les Turner/Lois Insolia ALS CenterNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations